Ji-Xiao Zhu (Jixiao Zhu)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Inflammatory Response

Major Depressive Disorder

Ulcerative Colitis

Lipopolysaccharide Induced

Top Venues

Metabolic brain disease

The Journal of pharmacy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Cheng-Fu Li, Qiu-Ping Zhang, Jie Cheng, Guang-Hui Xu, Ji-Xiao Zhu, Li-Tao Yi
Role of ginsenoside Rb1 in attenuating depression-like symptoms through astrocytic and microglial complement C3 pathway. Metabolic brain disease 39 (6) (2024)
Yiwei Shi, Guoyue Zhong, Huilian Huang, Nazhi Li, Jinxiang Zeng, Ji-Xiao Zhu, Jinbin Yuan, Jian Liang
Comparative pharmacokinetics of five primary constituents in Huai-hua powder: a study on normal rats and rats with ulcerative colitis. The Journal of pharmacy and pharmacology 76 (9) (2024)
Yiwei Shi, Guoyue Zhong, Huilian Huang, Nazhi Li, Jinxiang Zeng, Ji-Xiao Zhu, Jinbin Yuan, Jian Liang
Comparative pharmacokinetics of five primary constituents in Huai-hua powder: a study on normal rats and rats with ulcerative colitis. The Journal of pharmacy and pharmacology (2024)
Cheng-Fu Li, Qiu-Ping Zhang, Jie Cheng, Guang-Hui Xu, Ji-Xiao Zhu, Li-Tao Yi
Role of ginsenoside Rb1 in attenuating depression-like symptoms through astrocytic and microglial complement C3 pathway. Metabolic brain disease (2024)
Cheng-Fu Li, Qiu-Ping Zhang, Jie Cheng, Guang-Hui Xu, Ji-Xiao Zhu, Li-Tao Yi
Role of ginsenoside Rb1 in attenuating depression-like symptoms through astrocytic and microglial complement C3 pathway. Metabolic brain disease 39 (6) (2024)